{name}
{subtitle}
A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
city
~27 mi. (Ourense, Spain, +156 more cities)
facility
Complejo Hospitalario Universitario Ourense /ID# 222876
biomarker
IGH-CCND1 Fusion, +1 more biomarker
drug
dexamethasone, +1 more drug
drug type
chemotherapy, +1 more type
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
city
~70 mi. (Vigo, Spain, +383 more cities)
facility
Complexo Hospitalario de Vigo. Hospital Álvaro Cunqueiro; Servicio de Oncología
biomarker
ER Negative, +2 more biomarkers
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +1 more type
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
city
~70 mi. (Vigo, Spain, +260 more cities)
facility
Hospital Alvaro Cunqueiro; Servicio de Oncologia
biomarker
ERBB2 Amplification, +1 more biomarker
drug type
immunotherapy, +1 more type
A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)
city
~70 mi. (Vigo, Spain, +115 more cities)
facility
Complexo Hospitalario de Vigo. Hospital Álvaro Cunqueiro; Servicio de Oncología
biomarker
ERBB2 Amplification, +7 more biomarkers
drug type
immunotherapy, +1 more type
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
city
~89 mi. (Lugo, Spain, +130 more cities)
facility
Hospital Universitario Lucus Augusti ( Site 0852)
drug
BCG solution, +1 more drug
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)
city
~94 mi. (Santiago de Compostela, Spain, +147 more cities)
facility
Hosp Clin Univ de Santiago ( Site 0629)
condition
Cervical Adenocarcinoma, +2 more conditions
drug
brachytherapy, +3 more drugs
drug type
chemotherapy, +2 more types